Примери за използване на Body clearance на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Total body clearance was 4119 ml/h.
Inter individual variation in total body clearance was approximately 50%.
Body clearance of silodosin was approximately 0.28 l/h/kg.
The mean total body clearance was 0.96 ml/ min/ kg.
After intravenous administration, eliglustat total body clearance was 86 L/h.
Average total body clearance is approximately 2.25 i/ h.
In children, elevated SGPT levels are associated with reduced drug total body clearance.
The apparent body clearance was 1.1 ml/ min/ kg.
Concomitant cisplatin therapy is associated with reduced total body clearance of etoposide.
The apparent body clearance is 4832± 2562 ml/min/m2.
In adult cancer patients with liver dysfunction,total body clearance of etoposide is not reduced.
Total body clearance(CLtot) from plasma is approximately 57 L/h.
Inter individual variation in total body clearance was approximately 50%.
The total body clearance of aripiprazole is 0.7 ml/ min/ kg, which is primarily hepatic.
Inter individual variation in total body clearance was approximately 50%.
The apparent total body clearance and apparent volume of distribution were not affected by the race of the subjects.
Prior use of cisplatin may also result in a decrease of etoposide total body clearance in children.
The average total body clearance is approximately 2.25 l/h.
Renal clearance of pegvisomant is negligible andaccounts for less than 1% of total body clearance.
Pomalidomide has a mean total body clearance(CI/F) of approximately 7-10 L/hr.
Total body clearance and the terminal elimination half-life are independent of dose over a range 100 to 600 mg/m2.
In healthy subjects, the average total body clearance estimated from whole blood concentrations was 2.25 L/h.
Terminal half-life increased from 7.3 to 9.2 hours and total body clearance decreased from 6.1 to 2.4 L/h.
The apparent total body clearance is 9.16 l/hr using a population approach.
Hepatic impairment does not significantly affect total body clearance of palonosetron compared to the healthy subjects.
The total body clearance of hydroxycarbamide in adult patients with Sickle Cell Disease is 0.17L/h/kg.
Severe renal impairment reduces renal clearance, however total body clearance in these patients is similar to healthy subjects.
Mean values for total body clearance and steady-state volume of distribution were 21 l/ h/ m2 and 113 l, respectively.
Since nilotinib and its metabolites are not renally excreted, a decrease in total body clearance is not anticipated in patients with renal impairment.
The mean apparent total body clearance of levofloxacin following a 500 mg single dose was 175 +/-29.2 ml/min.